BioCentury
ARTICLE | Company News

Nuron, PolyTherics deal

December 19, 2011 8:00 AM UTC

PolyTherics said Nuron exercised an option for exclusive, worldwide rights to TheraPEG site-specific PEGylation technology for use in developing and commercializing NU400, a long-acting form of NU100...